Dr. Fan Xuan earned his B.Sc. in bioengineering from Shandon Jianzhu University, followed by an M.Sc. and a Ph.D. in biochemistry and molecular biology from Southwest University. His graduate research focused on neurological cancers, with a specific interest in epigenetic regulation in glioblastoma. In 2018, he accepted a postdoctoral fellowship with Dr. Xiaobing Shi at UT MD Anderson Cancer Center and subsequently moved with his lab to Van Andel Institute. He is now in the lab of Dr. Hong Wen at Van Andel Institute, where he studies the histone reader ENL YEATS domain mutation in Wilms tumors.